welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
withdrawn

Stem Cell Therapy in Duchenne Muscular Dystrophy

key information

study id #: NCT02241434

condition: Duchenne Muscular Dystrophy

status: withdrawn

purpose:

The purpose of this study was to study the effect of stem cell therapy in patients with Duchenne Muscular Dystrophy.

intervention: Stem Cell

mechanism of action: Stem cell therapy to promote cellular regeneration

results: https://clinicaltrials.gov/ct2/show/results/NCT02241434

last updated: November 21, 2018

study details

start date: January 2009

estimated completion: June 2016

phase of development: Phase 1

primary outcomes:

  • Manual Muscle Testing [ Time Frame: 1 year ]

secondary outcomes:

  • Brooke and Vignos Scale [ Time Frame: 1 year ]

inclusion criteria:
• age group of 3-25 years
• Duchenne muscular dystrophy diagnosed on the basis of clinical presentation

exclusion criteria:
• presence of respiratory distress
• presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus
• malignancies
• acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction < 30%
• pregnancy or breastfeeding

study contacts

sponsor: Neurogen Brain and Spine Institute

locations: India